8-K - Curanex Pharmaceuticals Inc Common Stock | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Curanex Pharmaceuticals Inc entered into employment agreements effective March 1, 2026, with CEO and President Jun Liu (annual base salary $393,600, 3-year term) and COO Dr. Liqin Xie (annual base salary $180,000, at-will employment), formalizing their prior uncompensated or partially compensated service and including equity eligibility, benefits, severance provisions, and restrictive covenants.

Key Takeaways

1Event Type: Executive Employment Agreements (Items: 5.02)

Current Report Details

Event Type

Material Agreement

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers C

Material Agreement

9.01

. Financial Statements and Exhibits (d) Exhibits. Exhibit No. Description 10.1 Employment Agreement between the Company and Jun Liu, effective March 1, 2026 10.

Exhibits Only

Executive & Director Changes

Jun Liu

Chief Executive Officer and President

Continued employment formalized

Effective: 2026-03-01

Dr. Liqin Xie

Chief Operating Officer

Continued employment formalized

Effective: 2026-03-01

Exhibits (3)

10.1

EX-10.1

10.2

EX-10.2

8-K